BridgeMD
New treatment option for Pneumonia
Official title Automated Oxygen Administration in Patients With Hypoxemic Pneumonia and Pleuropneumonia
ClinicalTrials.gov ID: NCT03527992
What this study is testing
- What it's testing
- Hypoxemic pneumonia is a major cause of hospitalization in Pulmonology. The patient's dependency on oxygen prevents early discharge from the hospital.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adult
- Patient living at home or in an institution
- Patient hospitalized for less than 48 hours
- Pneumonia defined (according to the 2006 French-speaking infectious pneumology society (SPILF) criteria) by:
- respiratory functional symptoms (cough, sputum, dyspnea, chest pain) and
You likely can't join if
- Pneumonia acquired at the hospital.
- Patient hospitalized in another department more than 48 hours before admission
- Chronic respiratory failure
- Active neoplasia
- Patients undergoing oxygen therapy and / or long-term NIV
- Associated cardiac decompensation (clinical signs and / or NTproBNP\> 1800ng / mL) (3
See the full eligibility criteria
- Adult
- Patient living at home or in an institution
- Patient hospitalized for less than 48 hours
- Pneumonia defined (according to the 2006 French-speaking infectious pneumology society (SPILF) criteria) by:
- respiratory functional symptoms (cough, sputum, dyspnea, chest pain) and
- Hyperthermia \>38,5°C or hypothermia \<36°C and
- Radiological Signs of Pneumonia
- Hypoxia : SpO2 \< 94% in ambient air and/or PaO2\< 60 mmHg in ambient air
- Pneumonia acquired at the hospital.
- Patient hospitalized in another department more than 48 hours before admission
- Chronic respiratory failure
- Active neoplasia
- Patients undergoing oxygen therapy and / or long-term NIV
- Associated cardiac decompensation (clinical signs and / or NTproBNP\> 1800ng / mL) (3
- Initial Need for high flow oxygen therapy or ventilatory support (NIV, VI)
- Difficulties expected from home support.
The study team makes the final eligibility decision.
Where it's taking place
- Toulouse, France
Compensation & support
Compensation likely.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Toulouse, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.